About
Technology
Issues
FAQ
Links
Official Page
Hyper‐CVAD plus ponatinib versus hyper‐CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A propensity score analysis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.